Compare ATRC & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | ASTH |
|---|---|---|
| Founded | 2000 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2005 | 2015 |
| Metric | ATRC | ASTH |
|---|---|---|
| Price | $34.15 | $46.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $51.17 | $34.86 |
| AVG Volume (30 Days) | ★ 1.1M | 778.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | N/A | ★ 0.29 |
| Revenue | $201,630,000.00 | ★ $519,907,752.00 |
| Revenue This Year | $15.27 | $27.38 |
| Revenue Next Year | $12.21 | $10.78 |
| P/E Ratio | ★ N/A | $161.41 |
| Revenue Growth | 15.40 | ★ 45.90 |
| 52 Week Low | $25.36 | $18.08 |
| 52 Week High | $43.18 | $51.60 |
| Indicator | ATRC | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 70.23 | 66.47 |
| Support Level | $34.16 | $36.47 |
| Resistance Level | $34.38 | $51.60 |
| Average True Range (ATR) | 1.50 | 2.17 |
| MACD | 0.62 | 0.11 |
| Stochastic Oscillator | 91.94 | 59.74 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.